Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease

Cytokine

Volumn 75, Issue 2, 2015, Pages 389-402

  Fonseca Camarillo, Gabriela ^a   Furuzawa Carballeda, Janette ^a   Yamamoto Furusho, Jesús K ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Crohn's disease; IDO; IL 37; Interleukin (IL) 35; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN 35; INTERLEUKIN 37; CD123 ANTIGEN; IL10 PROTEIN, HUMAN; IL37 PROTEIN, HUMAN; IL3RA PROTEIN, HUMAN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; ENZYME SYNTHESIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; BIOSYNTHESIS; COMPARATIVE STUDY; CROHN DISEASE; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; ULCERATIVE COLITIS; YOUNG ADULT;

ADULT; AGED; B-LYMPHOCYTES, REGULATORY; CD8-POSITIVE T-LYMPHOCYTES; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; INTERLEUKINS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84939775360     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.04.009     Document Type: Article

References (24)

1. Sartor B.R. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:390-407.
2. Sartor B.R. Animal models of intestinal inflammation. Kirsner's Inflammatory Bowel Diseases 2004, 120-137. Elsevier.
3. Fonseca-Camarillo G., Furuzawa-Carballeda J., Granados J., Yamamoto-Furusho J.K. Expression of IL-19 and IL-24 in IBD patients: a cross-sectional study. Clin Exp Immunol 2014, 177:64-75.
4. Fonseca-Camarillo G., Furuzawa-Carballeda J., Llorente L., Yamamoto-Furusho J.K. IL-10- and IL-20 expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J Clin Immunol 2013, 33:640-648.
5. Furuzawa-Carballeda J., Fonseca-Camarillo G., Lima G., Yamamoto-Furusho J.K. Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study. Clin Dev Immunol 2013, 2013:278035.
6. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen induced arthritis through the expansion of regulatory T cells and suppression of Th17cells. Eur J Immunol 2007, 37:3021-3029.
7. Li X., Mai J., Virtue A., Yin Y., Gong R., Sha X., et al. IL-35 is a novel responsive anti-inflammatory cytokine - a new system of categorizing anti-inflammatory cytokines. PLoS ONE 2012, 7:e33628.
8. Kochetkova I., Golden S., Holderness K., Callis G., Pascual D.W. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010, 184:7144-7153.
9. Shen P., Roch T., Lampropoulou V., O'Connor R.A., Stervbo U., Hilgenberg E., et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014, 507:366-370.
10. Wirtz S., Billmeier U., Mchedlidze T., Blumberg R.S., Neurath M.F. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 2011, 141:1875-1886.
11. Kumar S., McDonnell P.C., Lehr R., Tierney L., Tzimas M.N., Griswold D.E., et al. Identification and Initial characterization of four novel members of the interleukin-1 family. J Biol Chem 2000, 275:10308-10314.
12. Weidlich S., Bulau A.M., Schwerd T., Althans J., Kappler R., Koletzko S., et al. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2014, 59:e18-e26.
13. Quirk S., Agrawal D.K. Immunobiology of IL-37: mechanism of action and clinical perspectives. Expert Rev Clin Immunol 2014, 10:1703-1709.
14. Ye L., Ji L., Wen Z., Zhou Y., Hu D., Li Y., et al. IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activity. J Transl Med 2014, 12:69.
15. Chen B., Huang K., Ye L., Li Y., Zhang J., Fan X., et al. Interleukin-37 is increased in ankylosing spondylitis patients and associated with disease activity. J Transl Med 2015, 28:36-45.
16. Sutherland L.R., Martin F., Greer S., Robinson M., Greenberger N., Saibil F., et al. 5-Aminosalicylicacid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92:1894-1898.
17. Riley S.A., Mani V., Goodman M.J., Herd M.E., Dutt S., Tumberg L.A. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988, 94:1383-1389.
18. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
19. Frenz M.B., Dunckley P., Camporota L., Jewell D.P., Travis S.P. Comparison between prospective and retrospective evaluation of Crohn's disease activity index. Am J Gastroenterol 2005, 100:1117-1120.
20. Simera I., Moher D., Hoey J., Schulz K.F., Altman D.G. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010, 40:35-53.
21. Wang R.X., Yu C.R., Dambuza I.M., Mahdi R.M., Dolinska M.B., Serfeev Y.U., et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med 2014, 20:633-641.
22. Li Y., Wang Y., Liu Y., Wang Y., Zuo X., Li Y., et al. The possible role of the novel cytokines IL-35 and IL-37 in inflammatory bowel disease. Mediators Inflamm 2014, 2014:136329.
23. Imaeda H., Takahashi K., Fujimoto T., Kasumi E., Ban H., Bamba S., et al. Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol 2013, 172:410-416.
24. McNamee E.N., Masterson J.C., Jedlicka P., McManus M., Grenz A., Collins C.B., et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci USA 2011, 108:16711-16716.